Transamerica Financial Advisors LLC Buys New Shares in CME Group Inc. $CME

Transamerica Financial Advisors LLC bought a new position in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, HoldingsChannel.com reports. The fund bought 4,305 shares of the financial services provider’s stock, valued at approximately $951,000.

A number of other large investors have also bought and sold shares of CME. Whipplewood Advisors LLC increased its stake in CME Group by 2,075.0% in the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new position in shares of CME Group during the 4th quarter worth about $27,000. Hilton Head Capital Partners LLC acquired a new stake in shares of CME Group in the 4th quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of CME Group in the 2nd quarter valued at about $28,000. Finally, Legacy Wealth Managment LLC ID increased its position in CME Group by 191.9% in the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after buying an additional 71 shares in the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at CME Group

In related news, Director William R. Shepard purchased 325 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average cost of $230.57 per share, with a total value of $74,935.25. Following the transaction, the director owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This represents a 0.12% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.30% of the company’s stock.

CME Group Price Performance

Shares of NASDAQ CME opened at $280.98 on Thursday. The stock has a market cap of $101.03 billion, a price-to-earnings ratio of 23.83, a PEG ratio of 3.30 and a beta of 0.23. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. CME Group Inc. has a fifty-two week low of $218.31 and a fifty-two week high of $329.16. The firm’s 50-day simple moving average is $252.32 and its 200 day simple moving average is $279.24.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. The firm had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same period in the previous year, the company posted $2.96 EPS. As a group, research analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is 44.11%.

Wall Street Analysts Forecast Growth

CME has been the topic of several recent research reports. Erste Group Bank lowered CME Group from a “buy” rating to a “hold” rating in a report on Friday, June 5th. The Goldman Sachs Group decreased their price objective on CME Group from $267.00 to $245.00 and set a “sell” rating for the company in a report on Tuesday, June 30th. Weiss Ratings lowered CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Piper Sandler cut their target price on CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Finally, Barclays reduced their price target on shares of CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.